학술논문

Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study

Document Type

Article

Author

Schmid, P.; Salgado, R.; Park, Y.H.; Muñoz-Couselo, E.; Kim, S.B.; Sohn, J.; Im, S.-A.; Foukakis, T.; Kuemmel, S.; Dent, R.; Yin, L.; Wang, A.; Tryfonidis, K.; Karantza, V.; Cortés, J.; Loi, S.

Source

In Annals of Oncology May 2020 31(5):569-581

Subject

Breast tumor

Language

ISSN

0923-7534

Online Access

Full Text (ScienceDirect 종량제) Open Access (EBSCO) Full Text (ScienceDirect O/A) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송